HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Se Hoon Park Selected Research

Capecitabine (Xeloda)

6/2022A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer.
12/2018Deep Learning-Based Survival Analysis Identified Associations Between Molecular Subtype and Optimal Adjuvant Treatment of Patients With Gastric Cancer.
5/2017A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer.
6/2016Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin).
4/2016Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer.
1/2016To Excavate Biomarkers Predictive of the Response for Capecitabine plus RAD001 through Nanostring-Based Multigene Assay in Advanced Gastric Cancer Patients.
1/2016Factors Influencing Clinicians' Choice of Adjuvant S-1 versus Capecitabine plus Oxaliplatin after Curative Gastrectomy in Patients with Gastric Cancer.
10/2015Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study.
10/2015Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
1/2015Changes in the mean corpuscular volume after capecitabine treatment are associated with clinical response and survival in patients with advanced gastric cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Se Hoon Park Research Topics

Disease

133Neoplasms (Cancer)
09/2022 - 09/2004
92Stomach Neoplasms (Stomach Cancer)
01/2022 - 10/2004
25Carcinoma (Carcinomatosis)
07/2022 - 01/2009
24Disease Progression
05/2022 - 10/2004
23Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 08/2002
22Adenocarcinoma
01/2022 - 01/2004
21Neoplasm Metastasis (Metastasis)
12/2021 - 03/2008
14Renal Cell Carcinoma (Grawitz Tumor)
05/2022 - 01/2010
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2019 - 11/2003
10Prostatic Neoplasms (Prostate Cancer)
12/2021 - 11/2014
9Anemia
01/2018 - 09/2004
8Neutropenia
12/2020 - 11/2004
8Microsatellite Instability
01/2020 - 09/2010
8Pancreatic Neoplasms (Pancreatic Cancer)
11/2018 - 05/2009
7Urinary Bladder Neoplasms (Bladder Cancer)
07/2022 - 05/2012
7Fatigue
01/2022 - 04/2015
7Sarcoma (Soft Tissue Sarcoma)
01/2022 - 03/2015
7Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2021 - 02/2012
7Hepatocellular Carcinoma (Hepatoma)
08/2012 - 11/2004
6Colonic Neoplasms (Colon Cancer)
01/2020 - 09/2010
5Diarrhea
06/2022 - 01/2004
5Esophageal Squamous Cell Carcinoma
07/2017 - 01/2012
5Ascites
07/2016 - 01/2011
4Pain (Aches)
01/2022 - 03/2008
4Pneumonia (Pneumonitis)
12/2021 - 04/2015
4Fever (Fevers)
12/2021 - 12/2005
4Carcinogenesis
10/2018 - 08/2009
3Rectal Neoplasms (Rectal Cancer)
06/2022 - 02/2008
3Nausea
01/2022 - 05/2012
3Pruritus (Itching)
01/2022 - 10/2019
3Lymphatic Metastasis
09/2019 - 04/2015

Drug/Important Bio-Agent (IBA)

37Cisplatin (Platino)FDA LinkGeneric
05/2022 - 11/2003
27Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020 - 08/2002
23Capecitabine (Xeloda)FDA Link
06/2022 - 01/2004
21Docetaxel (Taxotere)FDA Link
12/2021 - 10/2004
21Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 01/2004
19PlatinumIBA
06/2022 - 01/2009
18Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 07/2005
17Biomarkers (Surrogate Marker)IBA
09/2022 - 08/2009
16GemcitabineFDA Link
05/2022 - 01/2005
13Proteins (Proteins, Gene)FDA Link
02/2021 - 09/2010
12Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 10/2004
12Pharmaceutical PreparationsIBA
10/2021 - 09/2009
12Leucovorin (Folinic Acid)FDA Link
01/2021 - 09/2005
11Immune Checkpoint InhibitorsIBA
09/2022 - 09/2019
11Tyrosine Kinase InhibitorsIBA
01/2022 - 06/2009
10B7-H1 AntigenIBA
01/2021 - 01/2016
9pazopanibFDA Link
04/2018 - 01/2014
8Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2015 - 06/2008
7Simvastatin (Zocor)FDA LinkGeneric
06/2022 - 09/2009
7EverolimusFDA Link
01/2018 - 07/2011
6Sunitinib (Sutent)FDA Link
01/2022 - 01/2010
6Cetuximab (Erbitux)FDA Link
01/2017 - 07/2013
6Hemoglobins (Hemoglobin)IBA
02/2016 - 01/2006
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 11/2004
5Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2022 - 01/2016
5Phosphotransferases (Kinase)IBA
10/2021 - 06/2011
5pembrolizumabIBA
01/2021 - 01/2018
5Trastuzumab (Herceptin)FDA Link
01/2020 - 03/2015
5Monoclonal AntibodiesIBA
01/2020 - 09/2015
5Gefitinib (Iressa)FDA Link
01/2020 - 07/2004
5ParaffinIBA
01/2014 - 06/2010
4Carboplatin (JM8)FDA LinkGeneric
05/2022 - 01/2005
4RamucirumabIBA
01/2022 - 01/2019
4RNA (Ribonucleic Acid)IBA
04/2020 - 02/2017
4regorafenibIBA
01/2020 - 01/2017
4Etoposide (VP 16)FDA LinkGeneric
01/2019 - 11/2003
4DNA (Deoxyribonucleic Acid)IBA
06/2017 - 04/2012
4Sorafenib (BAY 43-9006)FDA Link
01/2017 - 01/2011
3avelumabIBA
06/2022 - 01/2020
3human ERBB2 proteinIBA
01/2022 - 01/2019
3Messenger RNA (mRNA)IBA
02/2021 - 01/2017
3LigandsIBA
04/2020 - 02/2017
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2020 - 01/2014
31- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA
01/2020 - 04/2019
3Biological ProductsIBA
01/2020 - 02/2015
3atezolizumabIBA
01/2020 - 10/2019
3Bevacizumab (Avastin)FDA Link
01/2018 - 02/2013
3EnzymesIBA
01/2018 - 01/2013
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2017 - 03/2015
3XELOXIBA
05/2017 - 06/2011
3ErbB Receptors (EGF Receptor)IBA
10/2015 - 06/2009
3Formaldehyde (Formol)FDA Link
01/2014 - 10/2011

Therapy/Procedure

106Drug Therapy (Chemotherapy)
06/2022 - 01/2004
70Therapeutics
05/2022 - 11/2003
21Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 08/2002
14Chemoradiotherapy
06/2022 - 12/2003
12Radiotherapy
12/2020 - 10/2004
10Adjuvant Chemotherapy
01/2022 - 09/2010
8Immunotherapy
07/2022 - 01/2017
8Castration
12/2021 - 11/2014
6Gastrectomy
01/2021 - 01/2010
6Adjuvant Chemoradiotherapy
04/2020 - 12/2005
6Salvage Therapy
10/2019 - 11/2008
5Aftercare (After-Treatment)
01/2020 - 06/2007
5Precision Medicine
01/2018 - 06/2011
4Neoadjuvant Therapy
01/2022 - 05/2012
4Metastasectomy
01/2021 - 09/2010
3Cystectomy
07/2022 - 07/2018
3Lymph Node Excision (Lymph Node Dissection)
01/2016 - 01/2012